Lv5
938 积分 2024-05-30 加入
The Evolution of Antibody‐Drug Conjugates: Toward Accurate DAR and Multi‐specificity
10天前
已完结
A robust scale-down model development and process characterization for monoclonal antibody biomanufacturing using multivariate data analysis
1个月前
已完结
Exploiting mAb structure characteristics for a directed QbD implementation in early process development
2个月前
已完结
On the Doctrine of “Turning Knowledge into Wisdom”
2个月前
已完结
CRISPR‐interceded CHO cell line development approaches
3个月前
已完结
Poloxamer 188 as surfactant in biological formulations – An alternative for polysorbate 20/80?
3个月前
已完结
Biosimilar monoclonal antibodies: Challenges and approaches towards formulation
3个月前
已完结
Investigation of excipients impact on polysorbate 80 degradation in biopharmaceutical formulation buffers
3个月前
已完结
How enzymatic hydrolysis of polysorbate 20 influences colloidal protein stability
3个月前
已完结
An in-depth examination of fatty acid solubility limits in biotherapeutic protein formulations containing polysorbate 20 and polysorbate 80
3个月前
已完结
皖公网安备34019202002308
